Company Description
Caris Life Sciences is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer.
We develop and commercialize innovative solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Our entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets.
Our current commercial product portfolio is focused on oncology and consists of MI Profile, our tissue-based molecular profiling solution that has generated the majority of our revenue to date, and Caris Assure, our novel, universal blood-based molecular profiling solution that was broadly launched in the first quarter of 2024 for therapy selection.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,769 |
| CEO | David D. Halbert |
Contact Details
Address: 750 W. John Carpenter Freeway, Suite 800 Irving, TX 75039 United States | |
| Phone | (866) 771-8946 |
| Website | carislifesciences.com |
Stock Details
| Ticker Symbol | CAI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0002019410 |
| Employer ID | 85-2077369 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| David D. Halbert, D.Sc. (h.c.) | Founder, Chairman, and Chief Executive Officer |
| Brian J. Brille | Vice Chairman and Executive Vice President |
| David Spetzler, M.S., Ph.D., M.B.A. | President |
| Luke Power | Senior Vice President, Chief Financial Officer, and Chief Accounting Officer |
| J. Russel Denton | Senior Vice President, General Counsel, and Secretary |
| George H. Poste, D.V.M., Ph.D., D.Sc., F.R.S. | Vice Chairman |
| Jonathan Knowles, Ph.D. | Vice Chairman |
| Nathan Burns | Director |
| Peter M. Castleman | Director |
| David Fredrickson | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 23, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| May 8, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Apr 4, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Feb 7, 2025 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Dec 20, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Sep 12, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
| Jun 10, 2024 | DRS | [Cover] Draft Registration Statement |